Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 31, 2026.

The microbial metabolite p-Cresol induces autistic-like behaviors in mice by remodeling the gut microbiota

Patricia Bermudez-Martin, Jérôme A. J. Becker, Nicolas Caramello and 17 more

Microbiome · 2021 · CC BY

doi:10.1186/s40168-021-01103-z

Abstract

Background. Autism spectrum disorders (ASD) are associated with dysregulation of the microbiota-gut-brain axis, changes in microbiota composition as well as in the fecal, serum, and urine levels of microbial metabolites. Yet a causal relationship between dysregulation of the microbiota-gut-brain axis and ASD remains to be demonstrated. Here, we hypothesized that the microbial metabolite p-Cresol, which is more abundant in ASD patients compared to neurotypical individuals, could induce ASD-like behavior in mice.

Results. Mice exposed to p-Cresol for 4 weeks in drinking water presented social behavior deficits, stereotypies, and perseverative behaviors, but no changes in anxiety, locomotion, or cognition. Abnormal social behavior induced by p-Cresol was associated with decreased activity of central dopamine neurons involved in the social reward circuit. Further, p-Cresol induced changes in microbiota composition and social behavior deficits could be transferred from p-Cresol-treated mice to control mice by fecal microbiota transplantation (FMT). We also showed that mice transplanted with the microbiota of p-Cresol-treated mice exhibited increased fecal p-Cresol excretion, compared to mice transplanted with the microbiota of control mice. In addition, we identified possible p-Cresol bacterial producers. Lastly, the microbiota of control mice rescued social interactions, dopamine neurons excitability, and fecal p-Cresol levels when transplanted to p-Cresol-treated mice.

Conclusions. The microbial metabolite p-Cresol induces selectively ASD core behavioral symptoms in mice. Social behavior deficits induced by p-Cresol are dependant on changes in microbiota composition. Our study paves the way for therapeutic interventions targeting the microbiota and p-Cresol production to treat patients with ASD. Video abstract

Supplementary Information. The online version contains supplementary material available at 10.1186/s40168-021-01103-z.

References 98

  1. 1.

    Vuong HE, Hsiao EY. Emerging roles for the gut microbiome in autism spectrum disorder. Biol Psychiatry. 2017;81(5):411-423.

    Not in our library10.1016/j.biopsych.2016.08.024

  2. 2.

    Fombonne E, MacFarlane H, Salem AC. Epidemiological surveys of ASD: advances and remaining challenges. J Autism Dev Disord. 2021. 10.1007/s10803-021-05005-9.

    Not in our library10.1007/s10803-021-05005-9

  3. 3.

    Bourgeron T. Current knowledge on the genetics of autism and propositions for future research. C R Biol. 2016;339(7-8):300-307.

    Not in our library10.1016/j.crvi.2016.05.004

  4. 4.

    Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920):896-910.

    Not in our library10.1016/s0140-6736(13)61539-1

  5. 5.

    Mazurek MO, Vasa RA, Kalb LG, Kanne SM, Rosenberg D, Keefer A, Murray DS, Freedman B, Lowery LA. Anxiety, sensory over-responsivity, and gastrointestinal problems in children with autism spectrum disorders. J Abnorm Child Psychol. 2013;41(1):165-176.

    Not in our library10.1007/s10802-012-9668-x

  6. 6.

    Nikolov RN, Bearss KE, Lettinga J, Erickson C, Rodowski M, Aman MG, McCracken JT, McDougle CJ, Tierney E, Vitiello B, et al. Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord. 2009;39(3):405-413.

    Not in our library10.1007/s10803-008-0637-8

  7. 7.

    Gorrindo P, Williams KC, Lee EB, Walker LS, McGrew SG, Levitt P. Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors. Autism Res. 2012;5(2):101-108.

    Not in our library10.1002/aur.237

  8. 8.
  9. 9.
  10. 10.
  11. 11.
  12. 12.

    Emond P, Mavel S, Aidoud N, Nadal-Desbarats L, Montigny F, Bonnet-Brilhault F, Barthelemy C, Merten M, Sarda P, Laumonnier F, et al. GC-MS-based urine metabolic profiling of autism spectrum disorders. Anal Bioanal Chem. 2013;405(15):5291-5300.

    Not in our library10.1007/s00216-013-6934-x

  13. 13.

    Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res. 2010;9(6):2996-3004.

    Not in our library10.1021/pr901188e

  14. 14.

    Altieri L, Neri C, Sacco R, Curatolo P, Benvenuto A, Muratori F, Santocchi E, Bravaccio C, Lenti C, Saccani M, Rigardetto R, Gandione M, Urbani A, Persico AM. Urinary p-cresol is elevated in small children with severe autism spectrum disorder. Biomarkers. 2011;16(3):252-260.

    Not in our library10.3109/1354750x.2010.548010

  15. 15.

    Gabriele S, Sacco R, Cerullo S, Neri C, Urbani A, Tripi G, Malvy J, Barthelemy C, Bonnet-Brihault F, Persico AM. Urinary p-cresol is elevated in young French children with autism spectrum disorder: a replication study. Biomarkers. 2014;19(6):463-470.

    Not in our library10.3109/1354750x.2014.936911

  16. 16.

    Dieme B, Mavel S, Blasco H, Tripi G, Bonnet-Brilhault F, Malvy J, Bocca C, Andres CR, Nadal-Desbarats L, Emond P. Metabolomics study of urine in autism spectrum disorders using a multiplatform analytical methodology. J Proteome Res. 2015;14(12):5273-5282.

    Not in our library10.1021/acs.jproteome.5b00699

  17. 17.
  18. 18.
  19. 19.

    Kang DW, Ilhan ZE, Isern NG, Hoyt DW, Howsmon DP, Shaffer M, Lozupone CA, Hahn J, Adams JB, Krajmalnik-Brown R. Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders. Anaerobe. 2017;49:121-131.

    Not in our library10.1016/j.anaerobe.2017.12.007

  20. 20.

    Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155(7):1451-1463.

    Not in our library10.1016/j.cell.2013.11.024

  21. 21.

    Buffington SA, Di Prisco GV, Auchtung TA, Ajami NJ, Petrosino JF, Costa-Mattioli M. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell. 2016;165(7):1762-1775.

    Not in our library10.1016/j.cell.2016.06.001

  22. 22.

    Sgritta M, Dooling SW, Buffington SA, Momin EN, Francis MB, Britton RA, Costa-Mattioli M. Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder. Neuron. 2019;101(2):246-259.

    Not in our library10.1016/j.neuron.2018.11.018

  23. 23.

    Golubeva AV, Joyce SA, Moloney G, Burokas A, Sherwin E, Arboleya S, Flynn I, Khochanskiy D, Moya-Perez A, Peterson V, et al. Microbiota-related changes in bile acid & tryptophan metabolism are associated with gastrointestinal dysfunction in a mouse model of autism. EBioMedicine. 2017;24:166-178.

    Not in our library10.1016/j.ebiom.2017.09.020

  24. 24.

    de Theije CG, Wopereis H, Ramadan M, van Eijndthoven T, Lambert J, Knol J, Garssen J, Kraneveld AD, Oozeer R. Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun. 2014;37:197-206.

    Not in our library10.1016/j.bbi.2013.12.005

  25. 25.

    Sharon G, Cruz NJ, Kang DW, Gandal MJ, Wang B, Kim YM, Zink EM, Casey CP, Taylor BC, Lane CJ, Bramer LM, Isern NG, Hoyt DW, Noecker C, Sweredoski MJ, Moradian A, Borenstein E, Jansson JK, Knight R, Metz TO, Lois C, Geschwind DH, Krajmalnik-Brown R, Mazmanian SK. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell. 2019;177(6):1600-1618.

    Not in our library10.1016/j.cell.2019.05.004

  26. 26.

    Needham BD, Kaddurah-Daouk R, Mazmanian SK: Gut microbial molecules in behavioural and neurodegenerative conditions. Nat Rev Neurosci. 2020;21(12):717–31. 10.1038/s41583-020-00381-0. Epub 2020 Oct 16.

    Not in our library10.1038/s41583-020-00381-0

  27. 27.

    Needham BD, Adame MD, Serena G, Rose DR, Preston GM, Conrad MC, Campbell AS, Donabedian DH, Fasano A, Ashwood P, Mazmanian SK. Plasma and fecal metabolite profiles in autism spectrum disorder. Biol Psychiatry. 2021;89(5):451-462.

    Not in our library10.1016/j.biopsych.2020.09.025

  28. 28.

    Gevi F, Belardo A, Zolla L. A metabolomics approach to investigate urine levels of neurotransmitters and related metabolites in autistic children. Biochim Biophys Acta Mol Basis Dis. 1866;2020(10):165859.

    Not in our library10.1016/j.bbadis.2020.165859

  29. 29.

    Persico AM, Napolioni V. Urinary p-cresol in autism spectrum disorder. Neurotoxicol Teratol. 2013;36:82-90.

    Not in our library10.1016/j.ntt.2012.09.002

  30. 30.

    Saito Y, Sato T, Nomoto K, Tsuji H: Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites. FEMS Microbiol Ecol. 2018;94(9):fiy125. 10.1093/femsec/fiy125.

    Not in our library10.1093/femsec/fiy125

  31. 31.

    Passmore IJ, Letertre MPM, Preston MD, Bianconi I, Harrison MA, Nasher F, Kaur H, Hong HA, Baines SD, Cutting SM, Swann JR, Wren BW, Dawson LF. Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria. Plos Pathog. 2018;14(9):e1007191.

    Not in our library10.1371/journal.ppat.1007191

  32. 32.

    Hung LW, Neuner S, Polepalli JS, Beier KT, Wright M, Walsh JJ, Lewis EM, Luo L, Deisseroth K, Dolen G, et al. Gating of social reward by oxytocin in the ventral tegmental area. Science. 2017;357(6358):1406-1411.

    Not in our library10.1126/science.aan4994

  33. 33.

    Supekar K, Kochalka J, Schaer M, Wakeman H, Qin S, Padmanabhan A, Menon V. Deficits in mesolimbic reward pathway underlie social interaction impairments in children with autism. Brain. 2018;141(9):2795-2805.

    Not in our library10.1093/brain/awy191

  34. 34.

    Krishnan V, Stoppel DC, Nong Y, Johnson MA, Nadler MJ, Ozkaynak E, Teng BL, Nagakura I, Mohammad F, Silva MA, et al. Autism gene Ube3a and seizures impair sociability by repressing VTA Cbln1. Nature. 2017;543(7646):507-512.

    Not in our library10.1038/nature21678

  35. 35.
  36. 36.

    Bariselli S, Tzanoulinou S, Glangetas C, Prevost-Solie C, Pucci L, Viguie J, Bezzi P, O'Connor EC, Georges F, Luscher C, et al. SHANK3 controls maturation of social reward circuits in the VTA. Nat Neurosci. 2016;19(7):926-934.

    Not in our library10.1038/nn.4319

  37. 37.

    Lecca S, Luchicchi A, Scherma M, Fadda P, Muntoni AL, Pistis M. Delta(9)-tetrahydrocannabinol during adolescence attenuates disruption of dopamine function induced in rats by maternal immune activation. Front Behav Neurosci. 2019;13:202.

    Not in our library10.3389/fnbeh.2019.00202

  38. 38.

    Mandal S, Van Treuren W, White RA, Eggesbo M, Knight R, Peddada SD. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb Ecol Health Dis. 2015;26:27663.

    Not in our library10.3402/mehd.v26.27663

  39. 39.
  40. 40.

    Challand MR, Martins FT, Roach PL. Catalytic activity of the anaerobic tyrosine lyase required for thiamine biosynthesis in Escherichia coli. J Biol Chem. 2010;285(8):5240-5248.

    Not in our library10.1074/jbc.m109.056606

  41. 41.
  42. 42.

    Mir HD, Milman A, Monnoye M, Douard V, Philippe C, Aubert A, Castanon N, Vancassel S, Guerineau NC, Naudon L, et al. The gut microbiota metabolite indole increases emotional responses and adrenal medulla activity in chronically stressed male mice. Psychoneuroendocrinology. 2020;119:104750.

    Not in our library10.1016/j.psyneuen.2020.104750

  43. 43.

    Pascucci T, Colamartino M, Fiori E, Sacco R, Coviello A, Ventura R, Puglisi-Allegra S, Turriziani L, Persico AM: P-cresol alters brain dopamine metabolism and exacerbates autism-like behaviors in the BTBR mouse. Brain Sci. 2020;10(4):233. 10.3390/brainsci10040233.

    Not in our library10.3390/brainsci10040233

  44. 44.

    Lagkouvardos I, Pukall R, Abt B, Foesel BU, Meier-Kolthoff JP, Kumar N, Bresciani A, Martinez I, Just S, Ziegler C, et al. The Mouse Intestinal Bacterial Collection (miBC) provides host-specific insight into cultured diversity and functional potential of the gut microbiota. Nat Microbiol. 2016;1(10):16131.

    Not in our library10.1038/nmicrobiol.2016.131

  45. 45.

    Xiao L, Feng Q, Liang S, Sonne SB, Xia Z, Qiu X, Li X, Long H, Zhang J, Zhang D, Liu C, Fang Z, Chou J, Glanville J, Hao Q, Kotowska D, Colding C, Licht TR, Wu D, Yu J, Sung JJY, Liang Q, Li J, Jia H, Lan Z, Tremaroli V, Dworzynski P, Nielsen HB, Bäckhed F, Doré J, le Chatelier E, Ehrlich SD, Lin JC, Arumugam M, Wang J, Madsen L, Kristiansen K. A catalog of the mouse gut metagenome. Nature biotechnology. 2015;33(10):1103-1108.

    Not in our library10.1038/nbt.3353

  46. 46.

    Pellissier LP, Gandia J, Laboute T, Becker JAJ, Le Merrer J. mu opioid receptor, social behaviour and autism spectrum disorder: reward matters. Br J Pharmacol. 2018;175(14):2750-2769.

    Not in our library10.1111/bph.13808

  47. 47.

    Ranaldi R. Dopamine and reward seeking: the role of ventral tegmental area. Rev Neurosci. 2014;25(5):621-630.

    Not in our library10.1515/revneuro-2014-0019

  48. 48.

    Gunaydin LA, Grosenick L, Finkelstein JC, Kauvar IV, Fenno LE, Adhikari A, Lammel S, Mirzabekov JJ, Airan RD, Zalocusky KA, Tye KM, Anikeeva P, Malenka RC, Deisseroth K. Natural neural projection dynamics underlying social behavior. Cell. 2014;157(7):1535-1551.

    Not in our library10.1016/j.cell.2014.05.017

  49. 49.
  50. 50.

    Lewis MH, Tanimura Y, Lee LW, Bodfish JW. Animal models of restricted repetitive behavior in autism. Behav Brain Res. 2007;176(1):66-74.

    Not in our library10.1016/j.bbr.2006.08.023

  51. 51.

    Kim CH. Immune regulation by microbiome metabolites. Immunology. 2018;154(2):220-229.

    Not in our library10.1111/imm.12930

  52. 52.

    Venkatesh M, Mukherjee S, Wang H, Li H, Sun K, Benechet AP, Qiu Z, Maher L, Redinbo MR, Phillips RS, Fleet JC, Kortagere S, Mukherjee P, Fasano A, le Ven J, Nicholson JK, Dumas ME, Khanna KM, Mani S. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity. 2014;41(2):296-310.

    Not in our library10.1016/j.immuni.2014.06.014

  53. 53.

    Bolognini D, Tobin AB, Milligan G, Moss CE. The pharmacology and function of receptors for short-chain fatty acids. Mol Pharmacol. 2016;89(3):388-398.

    Not in our library10.1124/mol.115.102301

  54. 54.

    Swann JR, Spitzer SO, Diaz Heijtz R: Developmental signatures of microbiota-derived metabolites in the mouse brain. Metabolites. 2020;10(5):172. 10.3390/metabo10050172.

    Not in our library10.3390/metabo10050172

  55. 55.

    Vuong HE, Pronovost GN, Williams DW, Coley EJL, Siegler EL, Qiu A, Kazantsev M, Wilson CJ, Rendon T, Hsiao EY. The maternal microbiome modulates fetal neurodevelopment in mice. Nature. 2020;586(7828):281-286.

    Not in our library10.1038/s41586-020-2745-3

  56. 56.

    Vanholder R, Bammens B, de Loor H, Glorieux G, Meijers B, Schepers E, Massy Z, Evenepoel P. Warning: the unfortunate end of p-cresol as a uraemic toxin. Nephrol Dial Transplant. 2011;26(5):1464-1467.

    Not in our library10.1093/ndt/gfr056

  57. 57.

    Gryp T, Vanholder R, Vaneechoutte M, Glorieux G: p-Cresyl sulfate. Kidney Int. 2020;97(6):1230–42. 10.1016/j.kint.2020.01.028. Epub 2020 Feb 17.

    Not in our library

  58. 58.

    Fulling C, Dinan TG, Cryan JF. Gut microbe to brain signaling: what happens in vagus. Neuron. 2019;101(6):998-1002.

    Not in our library10.1016/j.neuron.2019.02.008

  59. 59.

    Gonzalez-Arancibia C, Urrutia-Pinones J, Illanes-Gonzalez J, Martinez-Pinto J, Sotomayor-Zarate R, Julio-Pieper M, Bravo JA. Do your gut microbes affect your brain dopamine? Psychopharmacology (Berl). 2019;236(5):1611-1622.

    Not in our library10.1007/s00213-019-05265-5

  60. 60.

    Han W, Tellez LA, Perkins MH, Perez IO, Qu T, Ferreira J, Ferreira TL, Quinn D, Liu ZW, Gao XB, Kaelberer MM, Bohórquez DV, Shammah-Lagnado SJ, de Lartigue G, de Araujo IE. A neural circuit for gut-induced reward. Cell. 2018;175(3):887-888.

    Not in our library10.1016/j.cell.2018.10.018

  61. 61.

    Loomes R, Hull L, Mandy WPL. What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2017;56(6):466-474.

    Not in our library10.1016/j.jaac.2017.03.013

  62. 62.

    Fiehn O. Metabolomics by gas chromatography-mass spectrometry: combined rargeted and untargeted profiling. Curr Protoc Mol Biol. 2016;114:30 34 31-30 34 32.

    Not in our library10.1002/0471142727.mb3004s114

  63. 63.

    Gao X, Pujos-Guillot E, Martin JF, Galan P, Juste C, Jia W, Sebedio JL. Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem. 2009;393(2):163-175.

    Not in our library10.1016/j.ab.2009.06.036

  64. 64.

    Korytowska N, Wyczalkowska-Tomasik A, Wisniewska A, Paczek L, Giebultowicz J. Development of the LC-MS/MS method for determining the p-cresol level in plasma. J Pharm Biomed Anal. 2019;167:149-154.

    Not in our library10.1016/j.jpba.2019.01.041

  65. 65.

    Santa T. Derivatization reagents in liquid chromatography/electrospray ionization tandem mass spectrometry. Biomed Chromatogr. 2011;25(1-2):1-10.

    Not in our library10.1002/bmc.1548

  66. 66.

    Becker JA, Clesse D, Spiegelhalter C, Schwab Y, Le Merrer J, Kieffer BL. Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity. Neuropsychopharmacology. 2014;39(9):2049-2060.

    Not in our library10.1038/npp.2014.59

  67. 67.

    Pujol CN, Pellissier LP, Clement C, Becker JAJ, Le Merrer J. Back-translating behavioral intervention for autism spectrum disorders to mice with blunted reward restores social abilities. Transl Psychiatry. 2018;8(1):197.

    Not in our library10.1038/s41398-018-0247-y

  68. 68.

    Leboucher A, Bermudez-Martin P, Mouska X, Amri EZ, Pisani DF, Davidovic L. Fmr1-deficiency impacts body composition, skeleton, and bone microstructure in a mouse model of fragile X syndrome. Front Endocrinol (Lausanne). 2019;10:678.

    Not in our library10.3389/fendo.2019.00678

  69. 69.

    Silverman JL, Yang M, Lord C, Crawley JN. Behavioural phenotyping assays for mouse models of autism. Nature reviews Neuroscience. 2010;11(7):490-502.

    Not in our library10.1038/nrn2851

  70. 70.

    Becker JAJ, Kieffer BL, Le Merrer J. Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine. THC and alcohol. Addict Biol. 2017;22(5):1205-1217.

    Not in our library10.1111/adb.12405

  71. 71.

    Matsuo N, Tanda K, Nakanishi K, Yamasaki N, Toyama K, Takao K, Takeshima H, Miyakawa T. Comprehensive behavioral phenotyping of ryanodine receptor type 3 (RyR3) knockout mice: decreased social contact duration in two social interaction tests. Front Behav Neurosci. 2009;3:3.

    Not in our library10.3389/neuro.08.003.2009

  72. 72.

    Katayama Y, Nishiyama M, Shoji H, Ohkawa Y, Kawamura A, Sato T, Suyama M, Takumi T, Miyakawa T, Nakayama KI. CHD8 haploinsufficiency results in autistic-like phenotypes in mice. Nature. 2016;537(7622):675-679.

    Not in our library10.1038/nature19357

  73. 73.

    Spencer CM, Alekseyenko O, Serysheva E, Yuva-Paylor LA, Paylor R. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav. 2005;4(7):420-430.

    Not in our library10.1111/j.1601-183x.2005.00123.x

  74. 74.

    Thomas A, Burant A, Bui N, Graham D, Yuva-Paylor LA, Paylor R. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl). 2009;204(2):361-373.

    Not in our library10.1007/s00213-009-1466-y

  75. 75.

    Moustgaard A, Hau J, Lind NM. Effects of dopamine D4 receptor antagonist on spontaneous alternation in rats. Behav Brain Funct. 2008;4(1):49.

    Not in our library10.1186/1744-9081-4-49

  76. 76.

    Le Marec N, Ethier K, Rompre PP, Godbout R. Involvement of the medial prefrontal cortex in two alternation tasks using different environments. Brain Cogn. 2002;48(2-3):432-436.

    Not in our library10.1006/brcg.2001.1393

  77. 77.

    Delotterie D, Ruiz G, Brocard J, Schweitzer A, Roucard C, Roche Y, Suaud-Chagny MF, Bressand K, Andrieux A. Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice. Psychopharmacology (Berl). 2010;208(1):131-141.

    Not in our library10.1007/s00213-009-1712-3

  78. 78.

    Meirsman AC, Le Merrer J, Pellissier LP, Diaz J, Clesse D, Kieffer BL, Becker JA. Mice lacking GPR88 show motor deficit, improved spatial learning, and low anxiety reversed by delta opioid antagonist. Biol Psychiatry. 2016;79(11):917-927.

    Not in our library10.1016/j.biopsych.2015.05.020

  79. 79.

    Fernandez SP, Muzerelle A, Scotto-Lomassese S, Barik J, Gruart A, Delgado-Garcia JM, Gaspar P. Constitutive and acquired serotonin deficiency alters memory and hippocampal synaptic plasticity. Neuropsychopharmacology. 2017;42(2):512-523.

    Not in our library10.1038/npp.2016.134

  80. 80.

    Ungless MA, Grace AA. Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci. 2012;35(7):422-430.

    Not in our library10.1016/j.tins.2012.02.003

  81. 81.

    Fernandez SP, Broussot L, Marti F, Contesse T, Mouska X, Soiza-Reilly M, Marie H, Faure P, Barik J. Mesopontine cholinergic inputs to midbrain dopamine neurons drive stress-induced depressive-like behaviors. Nat Commun. 2018;9(1):4449.

    Not in our library10.1038/s41467-018-06809-7

  82. 82.

    Le Roy T, Debedat J, Marquet F, Da-Cunha C, Ichou F, Guerre-Millo M, Kapel N, Aron-Wisnewsky J, Clement K. Comparative evaluation of microbiota engraftment following fecal microbiota transfer in mice models: age, kinetic and microbial status matter. Front Microbiol. 2018;9:3289.

    Not in our library10.3389/fmicb.2018.03289

  83. 83.

    Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nature biotechnology. 2019;37(8):852-857.

    Not in our library10.1038/s41587-019-0209-9

  84. 84.
  85. 85.

    Kechin A, Boyarskikh U, Kel A. Filipenko M: cutPrimers: a new tool for accurate cutting of primers from reads of targeted next generation sequencing. J Comput Biol. 2017;24(11):1138-1143.

    Not in our library10.1089/cmb.2017.0096

  86. 86.

    Mohsen A, Park J, Chen YA, Kawashima H, Mizuguchi K. Impact of quality trimming on the efficiency of reads joining and diversity analysis of Illumina paired-end reads in the context of QIIME1 and QIIME2 microbiome analysis frameworks. BMC Bioinformatics. 2019;20(1):581.

    Not in our library10.1186/s12859-019-3187-5

  87. 87.

    Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581-583.

    Not in our library10.1038/nmeth.3869

  88. 88.

    Kuraku S, Zmasek CM, Nishimura O, Katoh K. aLeaves facilitates on-demand exploration of metazoan gene family trees on MAFFT sequence alignment server with enhanced interactivity. Nucleic Acids Res. 2013;41(Web Server issue):W22-W28.

    Not in our library10.1093/nar/gkt389

  89. 89.

    Katoh K, Rozewicki J, Yamada KD. MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization. Brief Bioinform. 2019;20(4):1160-1166.

    Not in our library10.1093/bib/bbx108

  90. 90.

    Price MN, Dehal PS, Arkin AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol. 2009;26(7):1641-1650.

    Not in our library10.1093/molbev/msp077

  91. 91.
  92. 92.
  93. 93.
  94. 94.

    Bazinet AL, Ondov BD, Sommer DD, Ratnayake S. BLAST-based validation of metagenomic sequence assignments. PeerJ. 2018;6:e4892.

    Not in our library10.7717/peerj.4892

  95. 95.
  96. 96.
  97. 97.
  98. 98.

Cited by papers we hold 4

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.